Cleveland Cord Blood Center receives FDA biologics license for stem cell product – Crain’s Cleveland Business
Cleveland Cord Blood Center receives FDA biologics license for stem cell productCrain’s Cleveland BusinessThe Cleveland Cord Blood Center announced it has been issued a biologics license from the U.S. Food and Drug Administration for CLEVECORD, a stem … Continue reading
